Yilmaz U - Search Results

1

Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QT interval and dispersion in patients with gastrointestinal system cancers.

Oztop I, Gencer M, Okan T, Yaren A, Altekin E, Turker S, Yilmaz U. Oztop I, et al. Among authors: yilmaz u. Jpn J Clin Oncol. 2004 May;34(5):262-8. doi: 10.1093/jjco/hyh047. Jpn J Clin Oncol. 2004. PMID: 15231861 Clinical Trial.

2

5-fluorouracil increases the number and complexity of premature complexes in the heart: a prospective study using ambulatory ECG monitoring.

Yilmaz U, Oztop I, Ciloglu A, Okan T, Tekin U, Yaren A, Somali I, Alacacioglu A, Kirimli O. Yilmaz U, et al. Int J Clin Pract. 2007 May;61(5):795-801. doi: 10.1111/j.1742-1241.2007.01323.x. Int J Clin Pract. 2007. PMID: 17493091

3

Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

Oztop I, Yilmaz U, Yavuzsen T, Yaren A, Tarhan O, Sagol O, Coker A, Alakavuklar M. Oztop I, et al. Among authors: yilmaz u. Chemotherapy. 2004 Jun;50(3):127-32. doi: 10.1159/000077886. Chemotherapy. 2004. PMID: 15282439 Clinical Trial.

4

Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.

Meydan N, Kundak I, Yavuzsen T, Oztop I, Barutca S, Yilmaz U, Alakavuklar MN. Meydan N, et al. Among authors: yilmaz u. Jpn J Clin Oncol. 2005 May;35(5):265-70. doi: 10.1093/jjco/hyi071. Epub 2005 Apr 26. Jpn J Clin Oncol. 2005. PMID: 15855175

5

Irinotecan combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced gastric carcinoma as the first-line chemotherapy.

Yilmaz U, Oztop I, Alacacioglu A, Yaren A, Tarhan O, Somali I. Yilmaz U, et al. Chemotherapy. 2006;52(5):264-70. doi: 10.1159/000094769. Epub 2006 Jul 26. Chemotherapy. 2006. PMID: 16873996

6

Gemcitabine plus infusional 5-fluorouracil and high dose leucovorin in advanced stage pancreatic cancer.

Oztop I, Alacacioglu A, Unek IT, Tarhan O, Somali I, Cokmert S, Yavuzsen T, Yilmaz U. Oztop I, et al. Among authors: yilmaz u. J BUON. 2010 Jul-Sep;15(3):462-9. J BUON. 2010. PMID: 20941811

7

Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan.

Oztop I, Demirkan B, Yaren A, Tarhan O, Sengul B, Ulukus C, Akin D, Sen M, Yilmaz U, Alakavuklar M. Oztop I, et al. Among authors: yilmaz u. Tumori. 2004 Sep-Oct;90(5):514-6. doi: 10.1177/030089160409000515. Tumori. 2004. PMID: 15656341

8

Clinical and electrocardiography changes in patients treated with capecitabine.

Koca D, Salman T, Unek IT, Oztop I, Ellidokuz H, Eren M, Yilmaz U. Koca D, et al. Among authors: yilmaz u. Chemotherapy. 2011;57(5):381-7. doi: 10.1159/000331645. Epub 2011 Oct 12. Chemotherapy. 2011. PMID: 21997165

9

Evaluation of the efficacy of modified De Gramont and modified FOLFOX4 regimens for adjuvant therapy of locally advanced rectal cancer.

Koca D, Oztop I, Yavuzsen T, Ellidokuz H, Yilmaz U. Koca D, et al. Among authors: yilmaz u. Asian Pac J Cancer Prev. 2011;12(12):3181-6. Asian Pac J Cancer Prev. 2011. PMID: 22471450 Free article.

10

Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, epirubicin and cisplatin (modified ECF) as adjuvant chemotherapy in resected gastric adenocarcinoma.

Unek IT, Unek T, Oztop I, Akman T, Atilla K, Ellidokuz H, Bora S, Sarioglu S, Yilmaz U. Unek IT, et al. Among authors: yilmaz u. Chemotherapy. 2012;58(3):233-40. doi: 10.1159/000339493. Epub 2012 Jul 25. Chemotherapy. 2012. PMID: 22832016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters